Bitcoin futures could open to floodgates of institutional money
Bitcoin jumped as much as 4.1% to $6,351 after CME Group said it will start offering trading the derivatives in the fourth quarter
New York: Bitcoin is spiking to a record after CME Group Inc. said it’s planning to launch bitcoin futures as the move could open the floodgates of investors who have been standing on the sidelines as bitcoin soared over 500% this year.
The cryptocurrency jumped as much as 4.1% to $6,351 after the CME said it will start offering trading the derivatives in the fourth quarter. Futures will be settled in cash based on a bitcoin index that CME started calculating in November.
The move comes after the Chicago Board Options Exchange said in August it’s exploring bitcoin derivatives opportunities, while the Commodity Futures Trading Commission in July registered cryptocurrency trading platform LedgerX as the first federally regulated cryptocurrency derivatives exchange and clearinghouse.
With bitcoin futures becoming mainstream, the next logical step seems to be a bitcoin exchange-traded fund, as the Securities and Exchange Commission had cited the lack of derivatives as one of the reasons for rejecting approval of the funds. ETFs and derivatives are likely to make bitcoin trading a lot more palatable for hedge funds and mutual funds, as the instruments will allow them to hedge for the digital asset’s volatility and avoid some of the hassles of investing in bitcoin directly. Bloomberg
- Bangladesh’s bulk drugs policy may hurt Indian exports
- Telematics-based insurance takes a big hit due to lack of data protection, IRDA’s fixed pricing laws
- Yes Bank gets Sebi nod for custodian of securities business
- Cuts in fuel prices can push India into debt trap: Arun Jaitley
- India seen leveraging Solar Alliance meeting for foreign policy
Editor's Picks »
- Sensex companies’ return on equity falls to 13-year low
- All new Mercedes-Benz diesel cars will be Bharat Stage VI compliant
- Lupin, Japan’s Nichi-Iko tie up to distribute biosimilar drug
- Piramal Capital grants Rs 200 crore to Appaswamy for land acquisition
- Myntra eyes 40% jump in sales during its End of Reason Sale in June
- RBI wants banks to discipline Indian corporates on working capital
- For stressed power assets resolution, patience is the virtue for banks, govt
- Exide’s valuation zooms as it claws back market share lost to Amara Raja
- Trapped in mid-cap stocks? What investors should do
- TCS share buyback shows absurdities of India’s repurchase rules